CRBU PEER ANALYSIS

Caribou Biosciences Inc — metric-by-metric comparison with peers and the industry median

CRBUCaribou Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CRBUIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CRBU	RTALB	MSB	TLX	Ind. Median
P/E	—	4.89	—	—	17.81
P/B	1.72	0.61●	—	6.56	3.49
EV/EBITDA	—	74.61●	—	123.31	14.92
P/S	15.66	6.67	31.91	3.34●	10.89

Financial Health
Metric	CRBU	RTALB	MSB	TLX	Ind. Median
Current Ratio	6.22●	1.21	—	1.43	5.90
Debt/Equity	26.4%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	0.81●	0.90	—	13.13	1.15

Profitability
Metric	CRBU	RTALB	MSB	TLX	Ind. Median
Net Margin	-1,189.1%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-83.5%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-63.0%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-999.5%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	CRBU	RTALB	MSB	TLX	Ind. Median
Rev. Growth	13.0%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	CRBU	ATRA	OBIO	PLX	CHRS	OVID	Ind. Median
P/E	—	—	—	12.46	—	—	17.81
P/B	1.72	-4.11●	3.07	2.84	2.71	0.97	3.49
EV/EBITDA	—	—	—	6.62	—	—	14.92
P/S	15.66	6.62	4.79	2.50●	4.54	27.02	10.89

Financial Health
Metric	CRBU	ATRA	OBIO	PLX	CHRS	OVID	Ind. Median
Current Ratio	6.22	2.16	7.03	3.15	1.56	10.17●	5.90
Debt/Equity	26.4%	-27.0%●	66.0%	12.6%	69.2%	0.7%	10.9%
NetDebt/EBITDA	0.81	-0.32	1.15	-1.94●	0.70	6.42	1.15

Profitability
Metric	CRBU	ATRA	OBIO	PLX	CHRS	OVID	Ind. Median
Net Margin	-1,189.1%	-40.9%	-167.0%	20.1%●	-323.5%	-339.3%	-125.7%
ROE	-83.5%	—	-161.1%	27.3%●	—	-18.8%	-47.5%
ROA	-63.0%	-23.1%	-68.4%	17.4%●	-47.6%	-15.7%	-35.8%
EBITDA Margin	-999.5%	-23.7%	-161.1%	29.2%●	-341.0%	-337.0%	-105.8%

Growth + Dividend
Metric	CRBU	ATRA	OBIO	PLX	CHRS	OVID	Ind. Median
Rev. Growth	13.0%	-88.4%	1,033.9%	27.8%	-76.3%	1,199.6%●	5.1%
NI Growth	—	—	—	292.3%	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CRBU

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.